Sen. Angus S. King Jr. Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Key Points

• Senator Angus S. King Jr. sold shares of UnitedHealth Group (NYSE:UNH) valued between $1,001 and $15,000 on July 15th, as disclosed in a filing on August 18th.
• UnitedHealth Group's stock reached $307.10, with a market cap of $278.13 billion, but reported lower than expected earnings of $4.08 per share, missing analyst estimates.
• The company announced a quarterly dividend of $2.21 per share, set to be paid on September 23rd, representing an annualized yield of 2.9%.

Senator Angus S. King Jr. (I-Maine) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 18th, the Senator disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 15th.

Senator Angus S. King Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Kirby NYSE: KEX on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of JPMorgan Chase & Co. NYSE: JPM on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Lowe's Companies NYSE: LOW on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOGL on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Arista Networks NYSE: ANET on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Uber Technologies NYSE: UBER on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Netflix NASDAQ: NFLX on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of PayPal NASDAQ: PYPL on 7/21/2025.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $3.7480 on Friday, reaching $307.0980. 14,832,214 shares of the stock were exchanged, compared to its average volume of 12,868,562. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a fifty day moving average price of $288.51 and a two-hundred day moving average price of $391.21. The firm has a market capitalization of $278.13 billion, a PE ratio of 13.31, a PEG ratio of 1.93 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. UnitedHealth Group's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of analyst reports. Truist Financial reduced their price target on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. Mizuho lowered their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. KeyCorp reduced their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. TD Securities reiterated a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $365.38.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at about $26,000. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $42,000. Finally, LFA Lugano Financial Advisors SA acquired a new position in UnitedHealth Group in the 2nd quarter worth $25,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is owned by company insiders.

About Senator King

Angus King (independent) is a member of the U.S. Senate from Maine. He assumed office on January 3, 2013. His current term ends on January 3, 2031. King (independent) ran for re-election to the U.S. Senate to represent Maine. He won in the general election on November 5, 2024.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.